Late diagnosis of ornithine transcarbamylase defect in three related female patients: Polymorphic presentations
- 1 January 2002
- journal article
- case report
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 30 (1) , 241-244
- https://doi.org/10.1097/00003246-200201000-00035
Abstract
To describe three female patients of one family with different phenotypes of the same mutation of the ornithine transcarbamylase gene. X-linked inherited ornithine transcarbamylase deficiency is the most frequent urea cycle disorder. Many of the hemizygous males die during the neonatal period. Women, who are mostly healthy carriers, can also develop symptomatic hyperammonemia. Case study. Intensive care unit and internal medicine unit at a university hospital. The 20-yr-old female propositus was hospitalized for unexplained coma. She had a history of headaches, recurrent vomiting, specific anorexia for high-protein foods, and an acute neurologic crisis with alleged food poisoning 8 yrs before. The present episode began with psychiatric symptoms and seizures treated by diazepam and valproate. This unexplained coma, associated with respiratory alkalosis and major brain swelling on brain computed tomography scan, revealed hyperammonemia leading to the diagnosis of ornithine transcarbamylase deficiency. Continuous venovenous hemodiafiltration and treatment with sodium benzoate and phenylbutyrate improved the situation. However, the patient had some neurologic sequelae. DNA studies have disclosed a pathogenic mutation in the ornithine transcarbamylase gene of the patient, her mother, and her sister. For the mother, the disease was overlooked despite the onset of unusual headaches and neurologic signs that mimicked a cerebral tumor 12 yrs before. The 28-yr-old sister of the propositus has always been asymptomatic, even during pregnancy. Diagnosis of urea cycle disorder should be considered in any patient with unexplained neurologic and psychiatric disorders with selective anorexia, even in adulthood. Unexplained coma with cerebral edema and respiratory alkalosis requires urgent measurement of ammonemia and metabolic work-up.Keywords
This publication has 22 references indexed in Scilit:
- Long-Term Treatment of Girls with Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1996
- Ornithine Transcarbamylase Deficiency in Females: An Often Overlooked Cause of Treatable EncephalopathyJournal of Child Neurology, 1995
- Seven new mutations in the human ornithine transcarbamylase geneHuman Mutation, 1994
- Heterozygote ornithine transcarbamylase deficiency presenting as symptomatic hyperammonemia during initiation of valproate therapyNeurology, 1992
- Hyperammonemia in Women with a Mutation at the Ornithine Carbamoyltransferase LocusNew England Journal of Medicine, 1990
- VALPROATE TOXICITY AND ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCYThe Lancet, 1986
- Natural History of Symptomatic Partial Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1986
- Risk of serious illness in heterozygotes for ornithine transcarbamylase deficencyThe Journal of Pediatrics, 1986
- Cerebral Dysfunction in Asymptomatic Carriers of Ornithine Transcarbamylase DeficiencyNew England Journal of Medicine, 1980
- HYPERAMMONÆMIAThe Lancet, 1962